Millions of Americans suffer from respiratory diseases, including Asthma and chronic obstructive pulmonary disease (COPD). Together, these two diseases affect the day-to-day lives of over 40 million patients in the U.S. Furthermore, respiratory allergies affect 10 percent of children under the age of 18. Not only do these diseases impact day-to-day functioning, but they can also be life-threatening.

Today, America’s biopharmaceutical companies are developing 130 medicines for the millions of patients affected by respiratory diseases. All these medicines in development are currently awaiting review by the U.S. Food and Drug Administration (FDA) or in clinical trials.

Read more about these innovative treatments here.